96 related articles for article (PubMed ID: 24671638)
1. Neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: a feasibility and safety study.
Leimkühler M; Hemmer PHJ; Reyners AKL; de Groot DJA; van Ginkel RJ; Been LB; de Bock GH; van Leeuwen BL
World J Surg Oncol; 2019 Jan; 17(1):14. PubMed ID: 30635070
[TBL] [Abstract][Full Text] [Related]
2. Is cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still beneficial in patients diagnosed with colorectal peritoneal metastasis who underwent palliative chemotherapy?
Cho HJ; Kim JW; Kim WR
Asian J Surg; 2024 Jan; 47(1):296-302. PubMed ID: 37648541
[TBL] [Abstract][Full Text] [Related]
3. Towards Equal Access to Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy and Survival in Patients with Isolated Colorectal Peritoneal Metastases: A Nationwide Population-Based Study.
van der Ven RGFM; van den Heuvel TBM; Rovers KPB; Nienhuijs SW; Boerma D; van Grevenstein WMU; Hemmer PHJ; Kok NFM; Madsen EVE; de Reuver P; Tuynman JB; van Erning FN; de Hingh IHJT
Ann Surg Oncol; 2024 Jun; 31(6):3758-3768. PubMed ID: 38453767
[TBL] [Abstract][Full Text] [Related]
4. Survival and quality of life following cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis of colonic origin.
Hill AR; McQuellon RP; Russell GB; Shen P; Stewart JH; Levine EA
Ann Surg Oncol; 2011 Dec; 18(13):3673-9. PubMed ID: 21674272
[TBL] [Abstract][Full Text] [Related]
5. Immune profile of patients with peritoneal carcinomatosis selected for CRS-HIPEC therapy.
Kleber J; Yang Zhou J; Weber F; Bitterer F; Hauer P; Kupke P; Kronenberg K; Geissler EK; Schlitt HJ; Hornung M; Hutchinson JA; Werner JM
Cancer Immunol Immunother; 2023 Nov; 72(11):3867-3873. PubMed ID: 37580610
[TBL] [Abstract][Full Text] [Related]
6. ASO Visual Abstract: Towards Equal Access to Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy and Survival in Patients with Isolated Colorectal Peritoneal Metastases-A Nationwide Population-Based Study.
van der Ven RGFM; van den Heuvel TBM; Rovers KPB; Nienhuijs SW; Boerma D; van Grevenstein WMU; Hemmer PHJ; Kok NFM; Madsen EVE; de Reuver P; Tuynman JB; van Erning FN; de Hingh IHJT
Ann Surg Oncol; 2024 Jul; 31(7):4749-4750. PubMed ID: 38658412
[No Abstract] [Full Text] [Related]
7. Treatment Strategies and Prognosis of Patients With Synchronous or Metachronous Colorectal Peritoneal Metastases: A Population-Based Study.
Bakkers C; Lurvink RJ; Rijken A; Nienhuijs SW; Kok NF; Creemers GJ; Verhoef C; Lemmens VE; van Erning FN; De Hingh IH
Ann Surg Oncol; 2021 Dec; 28(13):9073-9083. PubMed ID: 34076807
[TBL] [Abstract][Full Text] [Related]
8. Effect of Xiaoyutang Combined with Intraperitoneal Heat Perfusion Chemotherapy on Immune Function, Circulating mir, Prognosis, and Survival of Postoperative Patients with Colorectal Cancer.
Li L; Wang Y; Huang X; Sun J; Zhang J
Comput Math Methods Med; 2021; 2021():1619809. PubMed ID: 34950221
[TBL] [Abstract][Full Text] [Related]
9. Selecting Potential Targetable Biomarkers for Imaging Purposes in Colorectal Cancer Using TArget Selection Criteria (TASC): A Novel Target Identification Tool.
van Oosten M; Crane LM; Bart J; van Leeuwen FW; van Dam GM
Transl Oncol; 2011 Apr; 4(2):71-82. PubMed ID: 21461170
[TBL] [Abstract][Full Text] [Related]
10. The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery.
Prada-Villaverde A; Esquivel J; Lowy AM; Markman M; Chua T; Pelz J; Baratti D; Baumgartner JM; Berri R; Bretcha-Boix P; Deraco M; Flores-Ayala G; Glehen O; Gomez-Portilla A; González-Moreno S; Goodman M; Halkia E; Kusamura S; Moller M; Passot G; Pocard M; Salti G; Sardi A; Senthil M; Spiliotis J; Torres-Melero J; Turaga K; Trout R
J Surg Oncol; 2014 Dec; 110(7):779-85. PubMed ID: 25088304
[TBL] [Abstract][Full Text] [Related]
11. Peritoneal Metastasis: A Dilemma and Challenge in the Treatment of Metastatic Colorectal Cancer.
Xia W; Geng Y; Hu W
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067347
[TBL] [Abstract][Full Text] [Related]
12. Quality Standards for Surgery of Colorectal Peritoneal Metastasis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
García-Fadrique A; Estevan Estevan R; Sabater Ortí L
Ann Surg Oncol; 2022 Jan; 29(1):188-202. PubMed ID: 34435297
[TBL] [Abstract][Full Text] [Related]
13. The impact of ultrasound-guided bilateral rectus sheath block in patients undergoing cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy - a retrospective study.
Wang S; Liu P; Gao T; Guan L; Li T
BMC Anesthesiol; 2020 Aug; 20(1):197. PubMed ID: 32781985
[TBL] [Abstract][Full Text] [Related]
14. Cancer Survival Data Representation for Improved Parametric and Dynamic Lifetime Analysis.
Vandamme LKJ; Wouters PAAF; Slooter GD; de Hingh IHJT
Healthcare (Basel); 2019 Oct; 7(4):. PubMed ID: 31661787
[TBL] [Abstract][Full Text] [Related]
15. Systematic Review of Variations in Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Metastasis from Colorectal Cancer.
Yurttas C; Hoffmann G; Tolios A; Haen SP; Schwab M; Königsrainer I; Königsrainer A; Beckert S; Löffler MW
J Clin Med; 2018 Dec; 7(12):. PubMed ID: 30572653
[TBL] [Abstract][Full Text] [Related]
16. Treatment of intraoperatively detected peritoneal carcinomatosis of colorectal origin with cytoreductive surgery and intraperitoneal chemotherapy.
Canda AE; Arslan C; Terzi C; Sokmen S; Yavuzsen T; Ozkardesler S; Unlu M; Obuz F; Fuzun M
World J Surg Oncol; 2018 Mar; 16(1):70. PubMed ID: 29587771
[TBL] [Abstract][Full Text] [Related]
17. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival for peritoneal carcinomatosis from colorectal cancer: a systematic review and meta-analysis of current evidence.
Huang CQ; Min Y; Wang SY; Yang XJ; Liu Y; Xiong B; Yonemura Y; Li Y
Oncotarget; 2017 Aug; 8(33):55657-55683. PubMed ID: 28903452
[TBL] [Abstract][Full Text] [Related]
18. Short-term outcome in patients treated with cytoreduction and HIPEC compared to conventional colon cancer surgery.
Simkens GA; Verwaal VJ; Lemmens VE; Rutten HJ; de Hingh IH
Medicine (Baltimore); 2016 Oct; 95(41):e5111. PubMed ID: 27741129
[TBL] [Abstract][Full Text] [Related]
19. Cytoreduction and hyperthermic intraperitoneal chemotherapy: a feasible and effective option for colorectal cancer patients after emergency surgery in the presence of peritoneal carcinomatosis.
van Oudheusden TR; Braam HJ; Nienhuijs SW; Wiezer MJ; van Ramshorst B; Luyer MD; Lemmens VE; de Hingh IH
Ann Surg Oncol; 2014 Aug; 21(8):2621-6. PubMed ID: 24671638
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
